BRIM Biotechnology, Inc. (6885.TWO)
TWD 37.6
(0.0%)
TWD 37.6
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -596.88 Million | -171.87 Million | -112.56 Million | -127.11 Million | -114.05 Million |
| Net Income | -688.02 Million | -274.27 Million | -105.44 Million | -97 Million | -118.76 Million |
| Depreciation & Amortization | 5.4 Million | 3.96 Million | 3.82 Million | 3.81 Million | 4.91 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 47.78 Million | 35.32 Million | 7.06 Million | 2.33 Million | 1.14 Million |
| Change in working capital | 17.75 Million | 250 Thousand | -33.34 Million | 38.67 Million | -587 Thousand |
| Other non-cash items | -21.64 Million | -750 Thousand | -386 Thousand | -1.26 Million | -761 Thousand |
| Investing Cash Flow | -751.43 Million | 22.63 Million | 118.55 Million | -140.22 Million | -69 Thousand |
| Investments in PPE | -3.7 Million | -1.21 Million | -514 Thousand | -366 Thousand | -69 Thousand |
| Acquisitions | 14 Thousand | - | 56.76 Million | -137.57 Million | - |
| Investment purchases | -747.63 Million | 23.84 Million | 62.58 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -111 Thousand | 3000.00 | -271 Thousand | -2.29 Million | - |
| Financing Cash Flow | 1.45 Billion | 587.48 Million | 310.73 Million | -2.48 Million | 167.84 Million |
| Debt repayment | -4.17 Million | -3.67 Million | -3.6 Million | -3.5 Million | -3.43 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.41 Billion | 576.21 Million | 295.62 Million | - | - |
| Other Financing Activities | 51.37 Million | 14.94 Million | 18.7 Million | 1.02 Million | 171.28 Million |
| Accounts receivables | -1.41 Million | -319 Thousand | -5000.00 | 2.44 Million | -2.17 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -508 Thousand | -3.56 Million | -454 Thousand | -2.15 Million | 1.59 Million |
| Cash at beginning of period | 837.99 Million | 399.74 Million | 83.02 Million | 346.9 Million | -53.72 Million |
| Cash at end of period | 947.99 Million | 837.99 Million | 399.74 Million | 83.02 Million | -6.78 Million |
| Capital Expenditure | -3.7 Million | -1.21 Million | -514 Thousand | -366 Thousand | -69 Thousand |
| Effect of forex changes on cash | - | - | - | 5.95 Million | -6.78 Million |
| Net cash flow / Change in cash | 110 Million | 438.24 Million | 316.71 Million | -263.87 Million | 46.94 Million |
| Free Cash Flow | -600.59 Million | -173.08 Million | -113.08 Million | -127.48 Million | -114.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -94.04 Million | -38 Million | -263.85 Million | -688.02 Million | -263.85 Million | -66.07 Million |
| Depreciation & Amortization | 1.56 Million | 1.6 Million | 1.47 Million | 5.4 Million | 1.47 Million | 1.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.57 Million | 2.72 Million | 21.84 Million | 47.78 Million | 21.84 Million | 3.71 Million |
| Change in working capital | -6.77 Million | -10.14 Million | -205.5 Thousand | 17.75 Million | -205.5 Thousand | 7.24 Million |
| Other non-cash items | -12.09 Million | -19.39 Million | 13.98 Million | -21.64 Million | 13.98 Million | -4.58 Million |
| Investing Cash Flow | 211.65 Million | -3.67 Million | -375.1 Million | -751.43 Million | -375.1 Million | -466 Thousand |
| Investments in PPE | -751 Thousand | -1.17 Million | -582.5 Thousand | -3.7 Million | -582.5 Thousand | -466 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -544.33 Million | - | -747.63 Million | - | - |
| Sales/Maturities of investments | 212.5 Million | 541.83 Million | - | - | - | - |
| Other Investing Activities | -90 Thousand | -3.5 Million | -374.51 Million | -111 Thousand | -374.51 Million | - |
| Financing Cash Flow | -976 Thousand | -1.08 Million | 730.17 Million | 1.45 Billion | 730.17 Million | -1.06 Million |
| Debt repayment | - | -1.08 Million | - | -4.17 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.41 Billion | - | - |
| Other Financing Activities | -976 Thousand | - | 730.17 Million | 51.37 Million | 730.17 Million | - |
| Accounts receivables | -535 Thousand | -765 Thousand | -711.5 Thousand | -1.41 Million | -711.5 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6.24 Million | -33 Thousand | 506 Thousand | -508 Thousand | 506 Thousand | - |
| Cash at beginning of period | 894.79 Million | 947.99 Million | - | 837.99 Million | - | 740.78 Million |
| Cash at end of period | 1 Billion | 894.79 Million | 128.32 Million | 947.99 Million | 128.32 Million | 691.35 Million |
| Capital Expenditure | -751 Thousand | -1.17 Million | -582.5 Thousand | -3.7 Million | -582.5 Thousand | -466 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 113.65 Million | -53.19 Million | 128.32 Million | 110 Million | 128.32 Million | -49.43 Million |
| Free Cash Flow | -97.77 Million | -49.6 Million | -227.33 Million | -600.59 Million | -227.33 Million | -48.36 Million |
MEI
SHAH
QCKSF
ITP
8279
0Q19